0001123292-19-000416.txt : 20190304
0001123292-19-000416.hdr.sgml : 20190304
20190304164539
ACCESSION NUMBER: 0001123292-19-000416
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190228
FILED AS OF DATE: 20190304
DATE AS OF CHANGE: 20190304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Roberts Eric W
CENTRAL INDEX KEY: 0001576244
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33389
FILM NUMBER: 19654487
MAIL ADDRESS:
STREET 1: VALENCE LIFE SCIENCES LLC
STREET 2: 500 PARK AVENUE 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VIVUS INC
CENTRAL INDEX KEY: 0000881524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943136179
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 E. HAMILTON AVENUE
STREET 2: SUITE 550
CITY: CAMPBELL
STATE: CA
ZIP: 95008
BUSINESS PHONE: 6509345200
MAIL ADDRESS:
STREET 1: 900 E. HAMILTON AVENUE
STREET 2: SUITE 550
CITY: CAMPBELL
STATE: CA
ZIP: 95008
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-02-28
0000881524
VIVUS INC
VVUS
0001576244
Roberts Eric W
C/O VIVUS, INC.
900 E. HAMILTON AVE., SUITE 550
CAMPBELL
CA
95008
1
0
0
0
Common Stock
2019-02-28
4
P
0
8500
4.8214
A
16660
D
This is the weighted average purchase price. Shares were purchased in multiple transactions at prices from $4.78 to $4.8998. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4. The amount reflected has been rounded to 4 decimal points.
/s/ Julie Hollenback, Attorney-in-Fact
2019-03-04